IMMUNOMODULATORY PROPERTIES OF NONI (Morinda citrifolia) by Lohani, Madhukar
Clemson University
TigerPrints
All Theses Theses
5-2010
IMMUNOMODULATORY PROPERTIES OF
NONI (Morinda citrifolia)
Madhukar Lohani
Clemson University, mlohani@clemson.edu
Follow this and additional works at: https://tigerprints.clemson.edu/all_theses
Part of the Medical Immunology Commons
This Thesis is brought to you for free and open access by the Theses at TigerPrints. It has been accepted for inclusion in All Theses by an authorized
administrator of TigerPrints. For more information, please contact kokeefe@clemson.edu.
Recommended Citation
Lohani, Madhukar, "IMMUNOMODULATORY PROPERTIES OF NONI (Morinda citrifolia)" (2010). All Theses. 806.
https://tigerprints.clemson.edu/all_theses/806
       
 
 
 
 
 
 
 
 
 
     IMMUNOMODULATORY PROPERTIES OF NONI (Morinda citrifolia) 
 
 
A Thesis 
Presented to 
the Graduate School of 
Clemson University 
 
 
In Partial Fulfillment 
of the Requirements for the Degree 
Master of Science 
Animal and Veterinary Science 
 
 
by 
Madhukar Lohani 
May, 2010 
 
 
Accepted by: 
Denzil V Maurice, Committee Chair 
Brandon D Moore 
Thomas R Scott 
Joe E Toler 
           
 
 
 
 
 
 
 
 
  
 
 
 
ABSTRACT 
 
 
Noni (Morinda citrifolia) is a popular medicinal plant of family Rubiaceae. Its 
fruit is rich in various phytochemicals and polysaccharides. Anecdotal evidence indicates 
that it was used to stimulate the immune system and, thus, to fight various infections. 
Limited in vitro studies also support the immunomodulatory role of Noni, however only 
one study utilized an animal model. The purpose of this study was to examine the 
immunomodulatory properties of Noni fruit the broiler chicken. 
Different concentrations of dietary Noni were added to diets and fed to day-old 
broiler chickens for 3 to 6 weeks. Gut tissue and blood were sampled to determine the 
expression of selected genes, concentration of immunoglobulins and α1-acid 
glycoprotein. The results showed that Noni at 6% concentration increased the expression 
of Toll like receptor -4 (TLR-4) and TLR-5, chemokine (IL-8), interleukin-12 (IL-12), 
and decreased the expression of IL-6 and TLR-7. At 4% concentration, Noni stimulated 
the expression of TLR-3. Increased expression of TLR-3, TLR-4 and TLR-5 indicate 
antiviral and antibacterial properties of Noni fruits in chickens that are further 
strengthened by increased expression of IL-12 and IL-8. Decreased expression of IL-6 
indicates anti-inflammatory properties of Noni. However, Noni did not have effects on 
serum and gut immunoglobulins or α1-acid glycoprotein concentration. Further 
investigations will be necessary to explore the active immunomodulatory ingredients of 
Noni and their effects on immunity during viral and bacterial infections. 
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CHAPTER I 
 
INTRODUCTION 
Herbal and natural products of folk medicine have been used for centuries in 
every culture throughout the world. Due to the prohibition of sub-therapeutic use of 
antibiotics in food animal industry by some countries, the possibility of a ban in other 
countries, and increasing demand for natural products with health benefits, the 
importance of medicinal plants have increased in recent years.   
Noni (Morinda citrifolia), also known as Indian Mulberry, Ba Ji Tian, Cheese 
Fruit and various other names in different countries, is a popular medicinal plant. Its fruit 
is rich in a variety of phytochemicals and polysaccharides. Results from limited studies 
demonstrated immunomodulatory effects of these constituents in in vitro experiments 
(Hirazumi et al., 1996, 1999, Furusawa et al., 2003, Pawlus et al., 2005 Akihisa et al. 
(2007). Considering the health benefits of Noni juice, the European Commission of 
Health and Consumer Protection accepted it as a novel food (Opinion of the Scientific 
Committee on Food on Tahitian Noni® Juice, 2002).   
      Health is directly related to the immune status of an animal. Gut mucosal 
immunity is important in this regards as the gut represents the largest surface area of the 
body that contacts with external milieu and thus interacts with diverse chemicals and 
infectious or non-infectious agents. Gut mucosa have some unique features to cope with 
these antigens. For example, the presence of the microfold cell (M cell) on mucosa 
facilitates the uptake of antigen from gut lumen to immune cells, which contain 
secondary lymphoid organs (e.g., Peyer’s patches) and thus stimulates the mucosal 
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immunity. Also, the total number of lymphocytes present in mucosal surface is greater 
than in primary lymphoid organs like spleen and lymph node. Macrophages and dendritic 
cells, present in these secondary lymphoid organs, are the first cells that interact with 
antigens, primarily via Toll-like receptors, and produce proinflammatory cytokines that 
further potentiate the immune response. Other cells, like B-1, of the innate immune 
system reside in secondary lymphoid tissue and are responsible for the secretion of 
natural antibodies. These antibodies neutralize a broad range of antigens including 
polysaccharides. Interestingly, in contrast to adaptive immunoglobulins, the production of 
natural antibody does not require T cells or prior exposure to the pathogen.  
The purpose of this study was to examine the immunomodulatory properties of 
Noni. The study was conducted in two phases. The first experiment determined whether 
dietary Noni supplementation enhanced antibody titers, which includes natural 
antibodies, during induced inflammation. The second experiment examined the effects of 
dietary Noni supplementation on gene expression of Toll-like receptors, proinflammatory 
cytokines, and chemokines in gut associated lymphoid tissue as well as systemic and gut 
associated antibody production. Supplementation of different concentrations of dietary 
Noni fruit puree to broilers, enhanced gene expression of Toll-like receptors, interleukins 
and chemokine, however did not effect immunoglobulin concentration. These results 
indicate immunomodulatory properties of Noni. 
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CHAPTER II 
LITERATURE REVIEW 
Introduction 
The Noni plant is one of approximately 11,000 species of the family Rubiaceae, some 
of which are used to treat various diseases. Also known as Indian Mulberry, Ba Ji Tian, 
Cheese fruit and various other names in different countries, it is the second most popular 
plant used for curative and preventive purposes in Polynesia (Krauss, 1993) as almost all 
of its parts in various combinations including root, stem, bark, fruits and leaves have been 
used to treat various known acute and chronic diseases in this region for 2000 years 
(Whistler, 1985; Bruggnecate, 1992). However, there are no written scientific documents 
discussing the ancient use of this fruit as an immunomodulator, even though anecdotal 
evidence indicates that it was used to fight various infections and therefore likely 
stimulated the immune system (Earle, 2001).  The current research focuses on the effect 
of the polysaccharides and phytochemicals of Noni on the immue system.  
                                                                                                                                  
                           Immunomodulatory Properties of Noni Fruit 
The results of recent studies support this role of Noni fruit (Sunder et al., 2007; Li et 
al., 2008; Zhang et al., 2009). The nutrient composition and chemical analyses of Noni 
fruit suggest that its polysaccharides and phytochemicals have immunomodulatory 
effects as evidenced by the results of in vitro experiments (Hirazumi et al., 1996, 1999; 
Furusawa et al., 2003; Pawlus et al., 2005; Desai et al., 2009).  
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Immunoglobulins and cytotoxic T-cells are the important components of humoral and 
cell-mediated immune system, which effectively eliminate the pathogen during infection. 
Sunder et al. (2007) first reported the effects of Noni fruit juice on humoral and cellular 
immunity. They found that supplementation to broiler chickens of 5% Noni crude fruit 
juice in drinking water to 6 weeks of age significantly increased the total antibody titers 
against goat red blood cells at 3 weeks of age. However, increment of total antibody titers 
does not necessarily reflect the enhancement of immune status as population of certain 
types of antibodies are required to neutralize or stimulate complement activation. Cell-
mediated immunity was measured by response to T-cell mitogen in terms of skin index to 
phytohaemagglutinin-P (PHA-P) injection measured 24-h post injection. The response to 
PHA-P was to be not found significant. To examine whether Noni-stimulated humoral 
immunity provided sufficient protection against infectious diseases, 3-week old broilers 
were challenged with infectious bursal disease virus (IBDV), and Noni treatment reduced 
approximately 75% mortality. However, it is thought that immunity against IBDV 
correlates with antibody titer, but enhancement of cell-mediated immunity is necessary 
for protection against the virus which was not affected by Noni in this experiment 
(Rautenschlein et al., 2002). Sensitivity of the technique to measure cell-mediated 
immunity and provision of Noni juice in drinking water, as only water soluble 
compounds were taken by broilers, might be factors that contributed to the lack of 
response to Noni treatment. The results of this study provide limited information about 
the immunomodulatory effects of Noni on immunity.  
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Schafer et al. (2008) utilized dairy calves as an animal model and reported that Noni 
fruits have antibacterial properties. Feeding 30 ml of Noni fruit puree twice a day per calf 
to newborn calves for up to 2 weeks enhanced bactericidal activities of blood against E. 
coli in an in vitro assay. Their findings need to be further investigated as the conclusion 
was based on the median differences not the true mean of the data. Based on the results, 
these authors hypothesized that the bactericidal activity of Noni may be due to the 
modulation of the neonatal immune system. To examine this hypothesis, Brook et al. 
(2009) measured the expression of alpha chain (CD25+) of IL-2 receptor on CD8+ and 
CD4+ T cells and found increased gene expression of CD25+ on these cells at 3 days of 
age. Activated IL-2 receptor transduces cell proliferation signal thus enhance immune 
cells population. To check whether the higher expression of this receptor correlated with 
the protection against bacterial infection, they supplemented 30 ml of Noni puree every 
12 h in Salmonella Dublin and Salmonella Newport infected calves and found a 54% 
reduction in total medical treatments per calf as compared to control. This study indicated 
the positive correlation of CD25+ with protection against infection, even though enhanced 
expression of β and γ subunits are necessary for signal transduction, and these were not 
examined. Based on these findings, Darien et al. (2009) determined whether Noni puree 
stimulates cell-mediated immunity or humoral immunity. They found that incubation of 
0.1 to 10 mg/ml concentration of Noni puree with isolated peripheral blood mononuclear 
cells for 4 or 24 h increased the secretion of IL-2, INF-γ, IL-4 and IL-5 in a dose 
dependent manner. Interestingly, incubation with Noni puree for 4 h induced a greater 
concentration of these cytokines as compared to 24 h incubation. This in vitro study 
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indicates that Noni puree potentiated cell-mediated, as well as humoral immunity. 
However, for providing the protection against infections it is necessary to examine the 
overall outcome of these cytokines in terms of immunoglobulins and different subsets of 
effector immue cell populations. Also, IL-4 and INF-γ have antagonizing effects on the 
immune response and thus affects the net outcome of immunity. 
To examine the possibility of Noni influencing neonatal immunity, the diet of dams 
was supplemented with puree, and gene expression was measured in umbilical cord 
blood. Noni supplementation during gestation increased gene expressions of Toll-like 
receptors (TLRs-1,-2,-4,-5, and 10), interleukins (IL-4, IL-17) and their receptors (IL-4R, 
IL-17RA, IL17RB), chemokine (CXCL11), co-stimulator CD27, TNF-α, and Foxp3. It is 
interesting that both IL-17 and Foxp3 expression are increased simultaneously, as IL-17 
stimulates the innate immune response while Treg cells, which are regulated by Foxp3, 
have a suppressive effect on immunity. 
Preventive as well as prophylactic treatments of mice with fermented Noni exudate or 
its supernatant showed antitumor activity against S180 tumor cells. Fermented Noni 
Exudate (fNE) or its supernatant at a dose of 500 µl/day/mouse for 3 days via i.p. 
injections increased the percentage of granulocytes and Natural Killer (NK) cells, and 
decreased the CD19+ B cells in spleen, peritoneum and peripheral blood of C57BL/7J 
mice (Li et al., 2008). These changes in immue responses were positively correlated with 
the survival of C57BL/7J mice challenged with S180 tumor cells. However they did not 
determine the expression of CD21 on B cells or dendritic cells to examine the 
complement modulatory activity of Noni as CD21 binds with the C3d component of 
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complement system. Interestingly, similar doses of Noni did not reduce the mortality in 
functional NK deficient beige mice. The results indicated that Noni shows anti-tumor 
activity via stimulating NK cells. Li et al. (2008) also observed that Noni treatment 
increased the duration of survival of thymus (T-cell producing organ) deficient nude mice 
but did not influence survivalibility. The suggestion that Noni may also modulate T cells 
which may help to eliminate the tumor with NK cells in C57BL/7J mice is supported by 
the fact that CD8+ cells are increased in C57BL/7J mice peritoneum. However, they also 
showed that Noni enhanced the memory of tumor immunity but they did not compare the 
treated data with survived tumor challenged mice from control group. According to the 
authors, Noni treatment provided long-term protection; i.e., anti-tumor memory 
development. It is not clear whether this was the result of either tumor challenge or Noni 
treatment due to insufficient information in control group.   
Incubation of pretreated LPS-matured dendritic cells with 1-10% fermented Noni 
Exudate (fNE) increased proliferation of syngeneic splenocytes that contain a variety of 
immune cells (Zhang et al., 2009). They further examined a subpopulation of splenocytes 
and found that B cells and CD4+ T cells increased significantly but that the population of 
NK cells and CD8+ cells was unaffected. These in vitro findings are contradicted by the 
in vivo findings of Li et al. (2008) that NK cells are increased in number due to fNE 
treatment. Proliferation of B cell was not directly stimulated by fNE, but the addition of 
immature or LPS matured dendritic cells enhanced B-cell proliferation. The highest 
proliferation was found at the fourth day of incubation. However it is conceivable that the 
responses to fNE are due to endotoxins such as lipopolysaccharides. The fNE used in the 
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study was analyzed and found to contain endotoxins and fNE positive for endotoxins 
stimulated proliferation. The proliferative activity was independent of CD-40 of B cells 
and required the direct contact between B cells and dendritic cells, and further allowed 
these cells to grow up to 3 weeks, resulting in increased IgG and IgM immunoglobulin 
concentrations. These findings suggest that fermentated Noni Exudate stimulates the 
humoral immune response via stimulating LPS matured dendritic cells or endotoxins in 
fNE induce the response.  
 
Immunomodulatory Polysaccharides in the Noni Fruit 
Analysis of alcohol precipitated fraction of Noni fruit showed that it contained 80% 
pectins and 5% protein-bound arabinogalactans (Bui et al., 2006). Similar purified 
polysaccharide fractions isolated from other plant sources exhibited immunological 
activities (Luettig et al. 1989; Chintalwar et al. 1999; Lim et al. 2003).  
Hirazumi et al. (1996, 1999) studied the effects of polysaccharide rich alcoholic 
precipitates of Noni on nitrite production by cultured mice peritoneal macrophage cells 
which contribute to bactericidal activity of macrophage. Fractions precipitated by 
repeated treatment with ethanol and solubilized in medium enhanced nitrite production. 
The same dose of solubilized Noni precipitates when combined with 25 U/ml of INF-γ 
exhibited a synergistic effect on nitrite production, which increased fourfold compared to 
solubilized precipitates, only. Incubation of different concentrations of precipitates with 
isolated human peripheral mononuclear cells for 24 hours increased the IL-1β and TNF-α 
production up to 30-250 pg/ml in a dose dependent manner and the relationship was 
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linear within the range of 100 to 1000 μg/ml of precipitates. Noni precipitates at 1.25 
µg/ml concentration also increased the IL-1β and IL-12 production from mice 
macrophage when incubated for 16 and 24 h, respectively. Incubation of similar 
concentration of Noni precipitates with splenocytes in the presence of mitogen inhibited 
IL-4, enhanced IL-10 production, but had no effect on IL-2 secretion. Similar incubation 
experiment with thymocytes increased INF-γ secreation. Polysaccharides of Noni also 
exhibited antitumor activity via modulating immune system (Hirazumi et al., 1999). 
Prophylactic and therapeutic treatments of Noni precipitates against LLC1 or S180 tumor 
cells challenged mice increased survivability and life span. Antitumor activity of Noni 
precipitates was abolished with simultaneous treatment of macrophage, NK cells or T cell 
inhibitors. Combined with interferon, the antitumor response of precipitates increased 
synergistically in both prophylactic and therapeutic treatments (Hirazumi et al., 1999; 
Furusawa et al., 2003). These results suggest that Noni polysaccharides stimulate cell-
mediated immunity, but the researchers did not examine the endotoxin contamination of 
Noni precipitates. The procedure did not eliminate the possibility of bacterial growth 
during exposure of ripe fruit to sunlight for 1-3 days prior to juice collection and 
preparation of precipitate  
Peritoneal exudate cells, from mice provided Noni juice at a dose of 100 ml for 15 
days, cultured with 3-12 µg/ml concentrations of concanavalin A in the presence of LPS 
decreased secretion of IL-4 (Palu et al., 2008). In the same study, incubation of 
polysaccharide-rich Noni precipitates with similar cells suppressed INF-γ production. 
This observation was contradictory to the finding of Hirazumi et al. (1996, 1999).  Palu et 
                                                                                                      9
  
 
 
 
al. (2008) correlated the immune suppression with increased binding of cannabinoid 
receptor-2 (CB-2) to its ligand by Noni fruit juice concentrate but they did not examine 
the effect of polysaccharide-rich precipitates on the receptor.  
Polysaccharides, hydroalcoholic and aqueous extracts, and alkaloids, and 
anthraquinone compounds extracted from the dried Noni fruit powder enhanced the 
phagocytic activity of neutrophils in in vitro assay. Oral dosing of these fractions also 
increased serum IL-6 in vaccine challenged mice (Nayak et al. 2009).  
 
Immunomodulatory Properties of the Phytochemicals 
Phytochemicals refer to the chemicals present in plants, which may or may not be 
nutrients, that affect health (Linus Pauling Institute of Micronutrient Research for 
Optimum Health). However, limited studies have been examined the effect of Noni fruit 
phytochemicals, but similar phytochemicals from the different sources have been 
reported to exhibit immunological properties (Table 2.1). The phytochemicals isolated 
from the Noni fruit belong to five major classes - iridoids, flavonoids, lignans, 
anthraquinones and fatty acid esters. (Wang et al., 1999, 2000; Su et al., 2005; Kamiya et 
al., 2004, 2005; Pawlus et al., 2005; Pawlus et al., 2005; Schripsema et al., 2006; 
Dalsgaard et al., 2006; Deng et al., 2007; Lin et al., 2007; Zin et al., 2007; Akihisa et al., 
2007 and Nayak et al. 2009). 
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Iridoids 
      Iridoids are terpenes synthesized from two isoprene (2-methyl-1, 3-butadiene) 
units and are intermediates in alkaloid biosynthesis. Chemically, iridoids consist of a 
cyclopentane ring fused with an oxygen heterocycle (Figure 2.1). 
                                                        
                         Figure 2.1 Chemical structure of iridoids 
Although the iridoids in the Noni fruit have not received much research attention, 
studying similar iridoids extracted from different plant sources have shown regulatory 
effects on immune cells in an in vitro model. For example, Cimanga et al. (2003) 
reported that gaertneroside, which structurally resembles the citrifolinoside of Noni fruit, 
inhibited the classical pathway of the complement system. Complement system is a 
biochemical pathway that either helps antibodies to eliminate antigen from the body or 
directly kill the pathogen. However, this study did not explore the affected component of 
complement pathway by the gaertneroside and thus provides limited information of anti-
complementary activity of iridoid. It seems that iridoids also check the adverse reactions 
of immune cells in the body, since deacetyl asperulosidic acid from Oldenlandia diffusa 
inhibited by 64% the oxidation of low density lipoproteins. This is one mechanism by 
which these phytochemicals can reduce atherosclerosis due to the oxidation of lipids by 
macrophages (Kim et al., 2005). Similarly, Li et al. (2006) reported that asperuloside and 
deacetylasperulosidic acid extracted from Lasianthus acuminatissimus, inhibit the 
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secretion of TNF-α by cultured mouse peritoneal macrophage cells, with IC50 values of 
0.52 and 1 µg/ml, respectively.  
 
                                               Flavonoids 
Flavonoids are a group of pigments present in plants. Chemically, flavonoids 
consist of two benzene rings linked with either a heterocycle pyran or pyrone ring 
(Middleton et al., 2000; Figure 2.2).  
                                                   
                             Figure 2.2  Chemical structure of flavonoids                         
       Quercetin, kaempferol and catechin isolated from different plants or in a 
chemically pure form have been investigated concerning their possible immunological 
properties in an in vitro model. The results indicate that quercetin inhibits antigen-
stimulated histamine release by human basophils and mast cells, over a range of 5 to 50 
µM in a dose dependent manner (Middleton et al., 1981; Grossman et al., 1988). 
Quercetin also inhibites leukocyte migration, and leukotriene-B4 (LTB-4) and 
prostaglandin-E2 (PGE2) concentrations in carrageenan-induced pleural exudates 
(Mascolo et al., 1988). In further investigation, these authors found that similar 
compounds inhibited the synthesis of ionophore-stimulated leukotriene B4 (LTB-4) in 
leukocytes. The phytochemicals, quercetin and kaempferol triglycosides extracted from 
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the leaves of Morinda morindoides (of the Noni genus) have been found to exhibit their 
anti-complementary activity on the classical and alternative pathways in an in vitro assay 
(Cimanga et al., 1995). However, this study did not examine the mechanism by which 
quercetin and kaempferol inhibited complement pathways and thus provides limited 
information of anti-complementary effects of these phytochemicals. 
       Flavonoids have also been found to affect cytokine production. Data obtained by 
Matsunaga et al. (2001) showed that epigallocatechin gallate reduced production of IL-
10, while at the same time stimulating production of IL-12 and TNF-α, and stimulating 
gene expression of INF-γ by bacterial induced cultured macrophages. Preincubation or 
coincubation of the polymeric or dimeric form of catechin or epicatechin reduced nitrous 
oxide secretion by stimulated macrophages in a concentration dependent manner, with an 
IC50 value of 50 μg/ml (Terra et al., 2007). Similarly, Shim et al. (2008) reported that 
epigallocatechin decreased T-cell proliferation and IL-2 secretion by inhibiting the 
MAPK and phospholipase-C pathways, via high affinity binding to ZAP-70 kinase (Kd 
of 0.6 µM). 
 
Lignans 
Lignans are important class of phytoestrogen found in plants. These are 
polyphenolic chemicals derived from phenylalanine and monolignols (Figure 2.3, 
Checker et al., 2007). 
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                                          Figure 2.3 Chemical structure of lignans 
       Epidemiological studies have suggested that lignans might be helpful in reducing 
the risk of breast, ovarian and prostate cancers in humans (Linus Pauling Institute of 
Micronutrient Research for Optimum Health). This potential anticancerous property may 
be due to their anti-proliferative effect on cancer cells. It appears that lignans may also 
suppress proliferation of immune cells. No lignans of Noni fruit have been studied for 
their immunomodulatory activities. However, a study conducted by Gredel et al. (2008) 
suggested that lignans can suppress the immune system. These researchers found that the 
coincubation of 10 µM of matairesinol inhibited the proliferation of peripheral 
mononuclear cells. They also reported that matairesinol and secoisolariciresinol had an 
inhibitory effect on IL-4, INF-γ and TNF-α secretion by the same cells at 50 µM (Gredel 
et al., 2008). 
 
Anthraquinones 
Anthraquinones contain two fused benzene rings with an oxygen heterocycle 
(Figure 2.4) and are abundantly found in the roots of a variety of plants. Based on mice 
and rat studies, conducted by the National Toxicological Program, anthraquinones are 
considered to be carcinogens (http://ntp.niehs.nih.gov/files). However, these are 
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considered non toxic in Noni fruits, since they are present in a trace amount (Pawlus et 
al., 2005). 
                                          
                                       Figure 2.4 Chemical structure of anthraquinones 
 
       For example, under in vitro conditions 0.9 pM concentration of 2-methoxy-1,3,6 
trihydroxyanthraquinone extracted from Noni fruit was required to double the activity of 
the phase II antioxidative enzyme, quinone reductase, as compared to 0.34 µM of the 
positive control L-sulforaphane. Based on these results, the concentration of Noni 
anthraquinone required to inhibit 50% of cell growth (ID50) for this compound was 7 
times higher than L-sulforaphane. These results indicate that the anthraquinones found in 
Noni fruit have extremely low toxic potential and may even have a beneficial effect on 
health (Pawlus et al., 2005). 
 
Fatty Acid Esters 
The fatty acid esters found in Noni fruit are primarily short chain fatty acids with a 
glucopyranose ring (Figure 2.5). 
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        Figure 2.5 Chemical structure of 6-O-(β-D-glucopyranosyl)-1-O-octanoyl-β-           
                                 glucopyranose 
 
       Akihisa et al. (2007) determined the anti-inflammatory effect of fatty acid esters 
isolated from Noni fruits by examining of the anti-inflammatory activity of the esters 
utilized mouse an animal model. They found that topical application of these esters [2-O-
(-D-glucopyranosyl)-1-O-octanoyl--D-glucopyranose, 2-O-(-D-glucopyranosyl)-1-O-
hexanoyl--D-glucopyranose, 6-O-(-D-glucopyranosyl)-1-O-octanoyl--D-
glucopyranose and 2,6 –di-O(-D-glucopyronosyl)-1-O-octanoyl--D-glucopyronose] 
inhibited 12-O-tetradecanoylphorbol-13-acetate (TPA) induced ear inflammation in mice 
with ID50 values, of 0.46-0.79 mg per ear.  
     
Miscellaneous Phytochemicals 
In addition to these 5 classes of phytochemicals, Noni fruits contain various other 
phytochemicals which also have immunomodulatory activities. For example, Su et al. 
(2005) found that the glycosidic form of -sitosterol palmitate showed strong anti-
complementary activity against the classical pathway in an in vitro assay with IC50 of 
1µM. This concentration was approximately 77 times lower than the control (Yoon et al., 
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2005). In further research, Desai et al. (2009) studied the effect of this phytochemical on 
immune cells, reporting that a 4 µM concentration of β sitosterol inhibited the release of 
IL-10 secretions from peripheral blood mononuclear cells isolated from multiple sclerosis 
patients compared to healthy individuals. However, it enhanced IL-10 secretion and 
reduced the proliferation of peripheral blood mononuclear cells isolated from healthy 
individuals at the same concentration compared to control.  
In addition, vanillin  (4-hydroxy-3-methoxybenzaldehyde) detected in the alcoholic 
extracts of Noni fruit inhibited carrageenan-induced paw edema of rats in a dose 
dependent manner, ranging from 12.5 mg/kg to 50 mg/kg per os. This inhibitory effect 
was correlated with the antioxidative activity of the compound in an in vitro assay (Lee et 
al., 2006). Similarly, Murakami et al. (2007) demonstrated that 100-500 μM 
concentrations of vanillin were potent inhibitors of LPS-stimulated cyclooxygenase-2 
(COX-2) expression in macrophages. 
 
  
 
 
 
                                           Immunomodulatory Properties of Noni Fruit 
Compounds  Immune  
 response 
 Anti-
complementary  
Anti-
inflammatory  
Anti-
oxidation 
References 
Iridoids      
Asperuloside -   + Li et al. (2006) 
Deacetylasperulosidic 
acid -   + 
Kim et al. (2005) 
Li et al. (2006) 
Flavonoids      
Quercetin - + + + 
Middleton et al. (1981) 
Cumella et al.(1987) 
Grossman et al. (1988) 
Mascolo et al. (1988) 
Aviram et al. (1998) 
Cimanga et al. (1995) 
Kaempferol 
triglycosides  +   
Cimanga et al. (1995) 
Catechin -    Terra et al. (2007) 
Epigallocatechin     Matsunaga et al. (2002) Shim et al. (2008) 
Lignans       
3,3’ 
bisdemethylpinoresin
ol   
   + 
Kamiya et al. (2004) 
Americanol A    + + Kamiya et al. (2004) 
Americanin A     + Kamiya et al. (2004) 
Americanoic acid A    + Kamiya et al. (2004) 
 
Anthraquinones      
 
2-methoxy-
trihydroxyanthraquin    + 
Pawlus et. al. (2005) 
  
 
 
       Table 2.1  Noni fruit phytochemicals and their biological activities 
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one 
Fatty Acid Ester -  +  Akihisa et al. (2007) 
Miscellaneous      
Β sitosterol -/+ +   Yoon et al. (2005)  Desai et al. (2009) 
Vanillin   + + Lee et al. (2006) Murakami et al. (2007) 
 
     
 
 
 
                  Note:  + and – sign and indicates the stimulatory and inhibitory effects on the response or activity. +/-      
                                          sign indicates both effects. 
 
                                 
 
 
 
 
 
 
 
 
 
 
 
 
                    
 
 
 CHAPTER III 
EFFECTS OF DIETARY NONI SUPPLEMENTATION ON IMMUNE 
RESPONSES AFTER LPS CHALLENGE IN BROILERS 
Materials and Methods 
                                                  Animals and Husbandry 
Day-old broiler chicks were obtained from a commercial hatchery. Chicks were 
provided with free access to water and practical corn-soy diet during the experiment. All 
procedures with chickens were approved by Clemson University Institutional Animal 
Care and Use committee.  
                           
                                   Experimental Design and Dietary Treatments 
The study was conducted using 108 day-old commercial broiler chickens 
distributed at random to 18 wire-floor pens (six birds per pen). A practical corn-soy diet 
was supplemented with either 0, 1 or 2% (w/w) concentrations of Noni crude fruit 
preparation to determine the minimum dose requirement of Noni that modulates 
immunity (Whole Noni fruit puree, 047-058-01, Morinda Agriculture Products Inc., 
Utah), and the three dietary treatments were assigned at random to the 18 pens to provide 
replications per treatment (n=6). The diets were fed from day-old to the 21 days of age. 
At 21 days of age, two pairs of birds were randomly selected from each pen, and each 
pair treated with either 2% lipopolysacchride (LPS) (L 7261, Sigma-Aldrich, St. Louis, 
MO) dissolved in normal saline or normal saline at 2mg/kg via intraperitoneal (i.p.) route. 
Blood and tissue samples were collected at 6 h and 24 h post LPS challenge.  
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                                                          Sample Collection 
To assess the systemic immunoglobulin concentration and serum α1-acid 
glycoprotein, blood samples were collected via cardiac puncture of birds at 6 and 24 
hours after LPS challenge. Serum was separated by centrifugation at 500 X g for 30 
minutes and stored at -4 0C until further analysis. For detection of gut tissue 
immunoglobulins, approximately 1 centimeter length of the gut tissue, along with its 
content, was cut from right side of Meckel‘s diverticulum (towards the ceca) after 
opening the abdominal cavity of the birds aseptically, and was stored at -800 C until 
further analysis. Feed consumption, body weight, liver, spleen, and bursa weights were 
also recorded. 
 
                                            Serological and Gut Tissue Analysis 
Serum IgA, IgM and IgG, and intestinal IgA antibodies were estimated by a 
sandwich enzyme-linked immunosorbent assay (ELISA) using kit (E30-102,-103,-104, 
Bethyl Laboratories, Montgomery, TX). Briefly, 96-well flat bottomed microtiter plates 
(01-010-3855, Dynatech, Chantilly, VA) were coated with 100 µl of a 1:100 dilution of 
goat antichicken IgG in coating buffer (0.05 M carbonate-bicarbonate buffer, pH 9.6) and 
incubated for 1 h. Plates were then washed five times with wash solution (50 mM Tris, 
0.14 M NaCl, 1% BSA, 0.05% Tween 20, pH 8.0) and blocked for 30 minutes using 200 
µl of blocking buffer (50 mM Tris, 0.14 M NaCl, 1% BSA, pH 8.0) to avoid non-specific 
binding on well surface. After washing, 100 µl of diluted serum (1: 20000, 1: 10000 and 
1: 5000 times for IgG, IgM, and IgA, respectively) in sample diluent (50 mM Tris, 0.14 
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 M NaCl, 0.05%Tween-20, 1% BSA, pH 8.0) and gut tissue supernatant in phosphate 
buffer saline (1:200) were then added and plates were incubated for 1 h. All samples were 
added in duplicate. Blanks (no test sample) and serial dilutions of chicken IgG, IgM or 
IgA standards were also included on each plate. Samples, those absorbance values were 
above than upper limit of standards’ absorbances or that had more than 10% variations in 
absorbance between duplicates were run again. Standards were run in each plate. 
Following incubation, plates were washed 5 times with wash solution and subsequently, 
100 µl horseradish peroxidase conjugated chicken IgG, IgM or IgA detection (diluted 1: 
10000 in sample diluents) antibodies were added and incubated for 1 h. After incubation, 
plates were washed five times with wash solution and 100 µl of substrate, ABTS [2, 2’ –
azino-bis (3- ethylbenzthiazoline-6-sulfonic acid)], was then added and plates were 
incubated for 15 minutes.  The absorbance was measured at 405 nm using a microplate 
reader (Thermomax model 1989) and calculated concentration using standard curve. All 
procedures were done at room temperature. The minimum detection limit of ELISA essay 
for IgA, IgG and IgM immunoglobulins were 15.625, 3.12, and 3.9 ng/ml, respectively. 
Intestinal IgA was extracted as described by Haghighi et al (2005), (Appendix 1), and 
results were expressed in terms of total soluble protein measured by the bicinchoninic 
acid (BCA) method (232-23,-24, Thermo Scientific, Rockford, IL). Serum α1- acid 
glycoprotein (AGP) was measured by chicken α1- acid glycoprotein measurement kit 
(P0801-1, The Institute for Metabolic Ecosystem, Miyagi, Japan). Briefly, plates with 
chicken anti-AGP antibody in agarose were used to measure AGP concentration by radial 
immunodiffusion assay. Five microliter test sample was applied to individual wells in 
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 plate. Chicken AGP standards were also applied to each plate and the plate placed in a 
humidified chamber at 370 C to incubate for 48 h. After incubation, outer diameter of 
each precipitin ring was measured and AGP concentration was calculated using the 
standard curve.  
 
Statistical Analysis 
Data collected were subjected to analysis of variance (ANOVA) using the general 
linear model procedure (GLM) of SAS (Version 9.1, SAS, Cary, NC). Response 
variables were analyzed using the CRD linear model, Yij = μ + αi + eij, where Y ij = 
variable measured; μ= overall mean; αi = the effect of ith level of dietary treatment; eij = 
random error for Jth pen receiving ith level of dietary treatment. Hartley's Fmax test was 
used to examine homogeneity of variance assumption. The difference between LPS 
challenge and control for each pen constituted the response variable in the case of organ 
weights, serum and gut immunoglobulins, and α1-acid glycoprotein.  
Orthogonal polynomial contrasts were used to examine relationships between 
response variables and dietary levels of Noni. Hypothesis tests for linear and quadratic 
responses were examined using α = 0.05. 
 
 
 
 
 
 
 
 
 
 
 23
  24
 
 
Results 
 
Results showed that performance in terms of body weight, feed conversion ratio 
and livability, and organ weights were not affected by Noni (P>0.05; all contrasts) (Table 
3.1). Dietary Noni did not affect serum IgG, IgM and IgA, and gut IgA concentrations 
after 6 h or 24 h post LPS challenge (P>0.05; all contrasts) (Table 3.2 and 3.3). A 
statistically significant departure from linearity was detected in serum IgM 24 hours post 
LPS challenge (P< 0.05) (Table 3.3). Serum IgA 24 h post LPS challenge exhibited a 
trend in deviation from linearity (P = 0.07) (Table 3.3). Linear or non-linear (quadratic) 
relationship was insignificant between other response variables and levels of Noni at 6 h 
or 24 h (P>0.05) (Table 3.1, 3.2 and 3.3)  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
                 Table 3.1 Performance and relative organ weights of broiler chicks fed dietary Noni from day-old to 3 weeks of age 
 
 
 
Liver2 
(g/g) 
Spleen2 
 (mg/g) 
Bursa2  
(mg/g) Diet
1 
(%Noni) 
Body 
weight  
(g) 
Feed 
conversion 
(g/g) 6 h  24 h 6 h  24 h 6 h  24 h 
0 8053 1.28 0.11 0.26 0.026 0.020 -0.068 0.010 
1 811 1.26 0.19 0.27 0.002 0.032 -0.049 -0.045 
2 794 1.29 0.01 0.23 0.182 0.002 -0.022 -0.014 
± SEM 9.1 0.010 0.10 0.24 0.009 0.015 0.043 0.033 
Linear  0.52 0.94 0.60 0.89 0.75 0.35 0.33 0.46 
Quadratic 0.36 0.38 0.96 0.35 0.06 0.89 0.90 0.64 
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                   1 Noni animal feed supplement (Morinda®) added to the diet (w/w). Survival was 100% for all diets 
 
                  2 The relative organ weights are expressed as the mean difference between birds challenged with lipopolysaccharide (2             
               mg/ kg body weight, i.p.) and controls that received saline measured at 6 and 24 hours post challenge. 
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Table 3.2   Immune responses of broiler chickens fed dietary Noni from day-old to 3 
weeks of age 6 h post LPS challenge. 
 
 
     Serum Immunoglobulin2         
                (mg/ml) 
Diet1 
(%Noni) 
Serum α- acid 
Glycoprotein2 
(µg/ml) IgM IgG IgA 
  Intestinal IgA2    
(ng/mg protein) 
0 793 0.14 0.45 0.03 -510 
1 66 0.16 0.60 -0.28 -636 
2 20 -0.01 0.62 -0.11 262 
± SEM 31.8 0.24 0.26 0.15 546 
P value 
Linear  0.15 0.28 0.40 0.49 0.57 
Quadratic 0.23 0.12 0.26 0.73 0.33 
  
1 Noni animal feed supplement (Morinda®) added to the diet (w/w). 
 
2 The response variables are expressed as the mean difference between birds   
  challenged with lipopolysaccharide (LPS, 2 mg/ kg body weight, i.p.) and controls that   
  received saline measured at 6 hours post challenge. 
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Table 3.3 Immune responses of broiler chickens fed dietary Noni from day-old to 3 
weeks of age 24 h post LPS challenge. 
 
 
 
     Serum Immunoglobulin2         
                (mg/ml) 
Diet1 
(%Noni) 
Serum α- acid 
Glycoprotein2 
(µg/ml) IgM IgG IgA 
  Intestinal IgA2       
(ng/mg protein) 
0 2183 0.30 -1.88  0.01 -379 
1 311 0.13 -0.19 -0.18 147 
2 347 0.40 0.58 -0.22 31 
± SEM 126 0.18 1.17 0.12 189 
P value 
Linear  0.44 0.28 0.19 0.12 0.60 
Quadratic 0.82 0.05 0.97 0.07 0.94 
 
 
1 Noni animal feed supplement (Morinda®) added to the diet (w/w). 
 
 
2 The response variables are expressed as the mean difference between birds 
  challenged with lipopolysaccharide (LPS, 2 mg/ kg body weight, i.p.) and controls that 
  received saline measured at 24 hours post challenge. 
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 Discussion 
In the present study, concentration of dietary Noni at 1% and 2% did not 
influence performance and immune responses in broiler chickens. The only significant 
response was a departure from linearity in serum IgM 24 hours post LPS challenge and a 
trend in deviation from linearity for serum IgA 24 hours post LPS challenge. The former 
is due to the lack of response to LPS challenge in birds fed 1% Noni and the latter due to 
non-responsiveness to LPS challenge in birds fed 1 or 2% Noni.  
Many factors can influence the determination of humoral immune response 
against LPS in chickens fed dietary Noni. Genetic differences in breeds (Van der Zijpp et 
al., 1983; Kundu et al., 1999) and lines (Kundu et al., 1999; Hangalapura et al., 2003; 
Parmentier et. al., 2004) of meat and layer chickens are associated with differences in 
natural or specific antibody (NAb) response. This finding is strengthened by the fact that 
at the molecular level, the distribution of Toll-like receptor-4 (TLR-4) is dependent on 
the genetic make-up of the birds (Dil et al., 2002). However, it is assumed that broilers 
are genetically similar due to selective line breeding, though, the production of NAb 
against different or same antigens is affected by linkage between the genes or by genetic-
environmental interaction, for example, different quantitative trait loci are associated with 
natural antibody responses against LPS in chicken (Siwek et al., 2006). Along with 
genetics, significant individual variation within treatment groups for gut IgA immune 
response may be ascribed to variability in the location of IgA producing B-cell rich 
Peyer’s patches within the chicken intestine. The sampling procedure may result in 
samples with little or no Peyer’s patches.  
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 The present experiment was designed to examine the effect of dietary Noni at 3 
weeks of age in chickens as GALT (Gut Associated Lymphoid Tissue) is fully functional 
two weeks post-hatching in broilers (Shira-Bar et al., 2003). Further, Lactobacillus 
species in broiler chickens are present predominantly in the small intestines at two weeks 
of age while some obligatory anaerobes become prominent in the ceca at 25 days of age 
(Romach et al., 2004). However, the number of CD3+ T cells continue to increase to 4-6 
weeks of age (Lillehoj et al., 1992) and the level of NAb in serum increases from 5 to 18 
weeks of age in layers (Siwek et al., 2006).  These factors may contribute to both 
individual variation and response of variables measured.  
Levels of maternal antibodies transferred to the chicks are directly related to the 
dam’s circulating concentration of antibodies (Hamal et al., 1996), which may differ 
among dams due to differences in genetic make-up; also, carry-over antibodies may 
persist up to 25-27 days in chicks and contribute to individual variation in antibody titer 
(Mahmud et al., 2007). Hence, serum IgG response in the study may have been affected 
by maternal antibodies. In addition to these factors, the limits of detection of the ELISA 
assay may also be a factor that contributes to failure to detect the effect of Noni on NAb 
as the detection limit of ELISA essay for IgA, IgG and IgM immunoglobulins were 
15.625, 3.12, and 3.9 ng/ml, respectively. 
  To date, the exact function of non-specific NAb in not clear, and it seems that it is 
less important in domesticated species of birds. Natural immunity was found to be lower 
in commercial layers as compared to their wild ancestor, Red Jungle Fowl (Mekchey et 
al., 1999). Hence, in addition to a follow-up study to examine gene expression, the effect 
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 of dietary Noni on vaccine-induced specific immunity against a commercially important 
specific viral or bacterial disease is warranted. 
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 CHAPTER IV 
 
EFFECTS OF DIETARY NONI SUPPLEMENTATION ON GENE EXPRESSION 
AND IMMUNOGLOBULINS IN BROILERS 
 
Materials and Methods 
 
Experimental Design and Dietary Treatments 
  Day-old commercial broiler chicks were distributed at random in wire-floor pens. 
A pen of six birds was the experimental unit. A practical diet was supplemented with 0, 4 
and 6% (w/w) concentrations of Noni crude fruit preparation (whole Noni fruit puree, Lot 
# 051-011-16, Morinda Agriculture Products Inc., Utah) and fed for 42 days. Treatments 
were assigned at random to 3 pens to provide 6 replications per treatment (n=6). At day 
42, birds from each pen were sampled for blood and tissue collection. To avoid the loss 
of phytochemicals, the Noni puree was stored at -4 0C and mixed in the diet on alternate 
days during the experiment.   
                                                          
Sample Collection 
To assess gene expression of cytokines, chemokine and Toll-like receptors, cecal 
tonsils were collected from both sides of the ileocecal junction (Appendix B). Blood 
samples were collected from cutanea ulnaris of the birds. Serum was separated from 
sampled blood by centrifugation at 500 X g for 30 minutes and stored at -4 0C till further 
analysis. For determination of gut IgA, a 6-cm portion of intact distal ileum (with 
contents) (approximately 5 cm cranial from the iliocecal junction) was sampled, placed in 
liquid nitrogen during collection and then stored at -800 C until further analysis. The 
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 mucosal scraping along with gut content of the intestine was used to determine the 
concentration of immunoglobulins. 
 
Serum and Gut Immunoglobulins Analysis 
Serum IgM and IgG, and gut (mucosal and luminal) IgA antibodies were 
estimated by using ELISA assay kit (L30-102,-103,-104, Bethyl Laboratory, 
Montgomery, TX). Intestinal IgA was extracted from gut content and mucosal scrapping 
as described by Haghighi et al. (2005) (Appendix A). The absorbance results were 
expressed in terms of total soluble protein measured by bicinchoninic acid (BCA) method 
(232-23,-24, Thermo Scientific, Rockford, IL).  
 
RNA Isolation, Quantification and Real-Time PCR 
Total RNA was isolated from the right cecal tonsil of each sample using RNeasy 
protect mini kit (74124, Qiagen Inc., Valencia, CA) as described in Appendix C. RNA 
was quantified at 260 nm wavelength (Eppendorf, Hamburg, Germany) and samples with 
mRNA purity of about 1.8 (ratio E260/E280) or above 1.8 (ratio E260/E280) were used. 
Contaminating DNA was digested using the RNase free DNase set (79245, Qiagen Inc., 
Valencia, CA) during RNA extraction and resulting RNA eluted in 50 µl RNase-free 
water per 30 mg tissue and stored at -80 O C. Real-Time PCR (QPCR) was done using the 
QuantiTechTM SYBR Green one step RT-PCR Kit (204243, Qiagen Inc., Valencia, CA) 
and a BIO-RAD thermocycler (Model IQ5), as described in Appendix D. QuantiTect 
SYBR Green RT-PCR master mix containing reverse transcriptase together with the 
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 QuantiTect RT Mix containing DNA polymerase allow both reverse transcription and 
amplification of transcript in a single tube. No-RNA template control and melting curve 
of gene specific PCR product were analyzed to cross check the primer dimer formation. 
No-RT control reaction was used to ensure the amplification of gene specific PCR 
product. The gene specific primers used for PCR are listed in appendix F. 
 
Semi-Quantitative RT-PCR and Gel Electrophoresis 
RT-PCR was done using ProtoScript M-MuLV Taq RT-PCR kit (E6400S, New 
England Biolab, Ipswich, MA) and BIO-RAD thermocycler (Model MJ mini, according 
to Appendix E). Two and one half microgram of total RNA was used for reverse 
transcription reaction, using 10 units of Moloney murine leukemia virus reverse 
transcriptase (RT), 2 µl of RT buffer, 2 µl of 50 µM oligo dT primer, 20 units of murine 
RNase inhibitor, 500 µM of dNTP  in a reaction mix of 20 μl RNase free water. Reverse 
transcription was performed to convert mRNA to cDNA at 42 oC for 60 minutes and 80 
oC for 5 minutes. 
PCR reaction were performed in a volume of 50 µl containing 2.5-5 µl of cDNA  
from the reverse transcriptase reaction, 200 nanomoles of each primer, 10 mM Tris-HCl 
(pH 8.6), 50 mM KCl, 1.5 mM MgCl2 , 200 µM dNTP, 0.05 % Tween-20, 5% glycerol 
and 1.25 units of Taq DNA polymerase. Before the start of the first cycle, all PCR were 
preceded by a denaturation step of 1 minute at 94 oC and the last cycle step was followed 
by a final elongation step of 10 minutes at 68 oC. Thirty five cycles  were used for IL-8 
and TLR-7 assays and 40 cycles were applied for IL-12 assay. The number of cycles was 
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 optimized to prevent the amount of PCR product from exceeding the upward slope of a 
typical cycle number-PCR product. The gene specific primers used for PCR reactions 
were similar to Real-Time PCR primers. Each PCR cycle contained denaturation at 94 oC 
for 30 seconds, annealing at 57 oC for 30 seconds and elongation at 68 oC for 60 seconds.  
Gene specific PCR products was separated in 1.5% agarose gels (32803, USB, Cleveland, 
OH) using 0.02% ethidium bromide for visualization. Band intensity was examined in 
ultraviolet light using an illuminometer and quantified using Image J software 
(www.rsb.info.nih.gov).  
 
Real-Time Data Analysis 
The data obtained from the QPCR, was analyzed using cycle number (Ct values). 
The cycle number at which the fluorescence crosses an arbitrary line called the threshold 
(i.e. when the fluorescence signal becomes detectable) is known as Ct value. Following 
treatment with 4% or 6% dietary Noni supplement, relative fold change of mRNA for the 
gene of interest was determined as described by Pfaffl (2001), using equation 1.  The 
initial RNA concentration was same for all samples and adjusted by diluting in RNase 
free water before performing Real-Time PCR. 
 
                                             (1 + E Target) ΔCt, Target 
   Fold expression =                                                                        (1) 
                                          (1 + E GAPDH, Control) ΔCt, GAPDH       
where, 
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 Δ Ct, Target = (Ct, Target, Control  -  Ct, Target,  Noni treatment) 
and  Δ Ct, GAPDH = ( Ct,GAPDH, Control  -  Ct, GAPDH,  Noni treatment) 
PCR efficiency of the target and reference gene was calculated by plotting the log of the 
RNA template dilution versus Ct value using the following equation: 
  
                                                     E  =10- (1/s) – 1                              (2) 
where s represents the slope of the line plotted for log of the template dilution versus log 
of Ct value. Standard curves were generated using 5 fold serial dilution of total cellular 
RNA from broiler chickens. Total cellular RNA used ranged from 200 ng to 12.5 ng. The 
efficiency of standard curves were listed in Table 4.1 
Table 4.1: Description of standard curves used in data analysis. 
Gene of Interest Efficiency R2 
GAPDH 0.93 0.99 
IL-1β 1.10 0.99 
IL-6 1.08 0.99 
IL-8 0.90 0.98 
IL-12 1.23 0.94 
TLR-3 0.94 0.98 
TLR-4 1.24 0.99 
TLR-5 1.69 0.90 
TLR-7 1.12 0.93 
 
 
Statistical Analysis 
ANOVA was performed using the general linear model (GLM) procedure of JMP 
statistical software (SAS Institute Inc., Cary, NC, USA), and hypothesis testing was 
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 conducted using α = 0.05. Response variables were analyzed using the following linear 
model:  
Yij = μ + αi + eij, where Y ij = variable measured; μ= overall mean; αi = the effect of ith 
level of dietary treatment; eij= random error associated with experimental unit. 
Normalized values of response variables were taken for statistical analysis. 
Normalization was done by dividing the Ct value of gene of interest to that of Ct value of 
internal control (GAPDH) of the sample. 
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 Results 
 
The objective of this experiment was to investigate the effects of dietary Noni 
crude fruit extract on target gene expression in broiler chickens. Genes included 
cytokines, chemokine, and Toll-like receptors in cecal tonsil, and immunoglobulin 
concentrations. Gel electrophoresis of PCR product showed the modulatory effects of 
Noni on IL-8, IL-12 and TLR-7 gene expression (Figures 4.1). Further analysis by Real -
time PCR reveled that 4% Noni treatment increased (1.9 fold) TLR-3 gene expression. 
However did not show any effect on the expression of other genes (Figure 4.2). Noni at 
6% inclusion increased the expression of IL-8 (3 fold), IL-12 (4 fold) and TLR-4 (2.6 
fold), and decreased gene expression of IL-6 (0.6 fold) and TLR-7 (0.3 fold) (Figure 4.3). 
TLR-5 gene expression was increased 1.7 and 2.3 fold by 4% and 6% Noni, respectively 
(Figures 4.2 and 4.3). Neither concentrations of Noni affected IL-1 gene expression 
(Figures 4.2 and 4.3). The values of coefficient of determination (R2) of standard curve 
for TLR-7, TLR-5 and IL-12 genes were 0.93, 0.90 and 0.94, respectively (Table 4.1) 
which were less as than R2 values obtained for other measured genes (0.98-0.99) (Table 
4.1). Dietary Noni supplementation did not have significant effects on the concentration 
of serum IgM and IgG or intestinal IgA (Table 4.2)    
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Table 4.2 Immune responses of broiler chickens fed dietary Noni from day-old to 6 
weeks of age 
 
 
   Serum Immunoglobulin2              
                 (mg/ml) 
Gut Immunoglobulin2 
(% Total protein) 
        Diet1 
      (%Noni) 
IgM IgG IgA 
0       0.30 1.32 ± 0.25 2.89  
4       0.25 1.47 1.91 
6       0.36 1.42 2.52 
         ± SEM       0.05 0.22 0.60 
 
1  Noni animal feed supplement provided by Morinda®, was supplemented to the diet           
   as w/w basis and fed from day-old to 6 weeks of age. 
 
2   Each pooled mean based on 5 samples except serum IgG in control group where   
   pooled mean is based on 6 samples. 
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 Figure 4.1 Effect of 6% dietary Noni supplement on gene expression in caecal tonsil of 
broilers fed to 6 weeks of age starting from day-old chicks using semi quantitative RT-
PCR. Gel electrophoresis was performed (Panel A). The band densities of gene specific 
PCR products were quantified using Image J software (http://rsb.info.nih.gov/ij/) and 
expressed as a percentage of their respective internal control GAPDH (Panel B). 
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Figure 4.2 Effect of 4% dietary Noni supplement on gene expression in caecal tonsil of 
broilers fed to 6 weeks of age using Real-Time PCR. 
P values are presented above the bar and P< 0.05 indicates the significant difference 
from the control group. Data are presented as mean of 5 samples (n=5) 
Gene expression of treatment group is expressed relative to control group according to 
Pfaffl (2001) method. 
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Figure 4.3 Effect of 6% dietary Noni supplement on gene expression in caecal tonsil of 
broilers fed to 6 weeks of age using Real-Time PCR.  
P values are presented above the bar and P< 0.05 indicates the significant difference 
from the control group. Data are presented as mean of 5 samples (n=5) 
Gene expression of treatment group is expressed relative to control group according to 
Pfaffl (2001) method. 
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 Discussion 
The observed increased TLR-3, TLR-4, IL-8 and IL-12 gene expression and 
decreased IL-6 and TLR-7 gene expression in gut associated caecal tonsil in chickens fed 
dietary Noni indicated that Noni crude fruit extracts have immunomodulatory properties. 
The immunomodulatory property of Noni fruit is supported by some in vitro studies 
(Hirazumi et al., 1996, 1999; Furusawa et al., 2003; Li et al., 2008; Zhang et al., 2009; 
Brooks et al., 2009). For example, Noni fruit polysaccharides increased IL-1 and TNF-α 
secretion from human peripheral mononuclear cells in a dose dependent manner               
and fermented Noni juice pretreated dendritic cells increased immunoglobulin secretion 
from B cells ((Hirazumi et al., 1996,  Zhang et al., 2009) 
Noni fruit is rich in phytochemicals and polysaccharides (Cimanga et al., 1995, 
Sang et al., 2003; Kamiya et al., 2004; Pawlus et al., 2005; Lin et al., 2007; Akisha et al., 
2007). Polysaccharides from Noni fruit have been reported to have immunomodulatory 
properties in vitro (Hirazumi et al., 1996, 1999; Furusawa et al., 2003). Also, some 
phytochemicals present in Noni fruit were shown to have immunomodulatory activity by 
modulating NF-kB signal transduction pathway in a dose dependent manner (Desai et al., 
2009; Murakami et al., 2007).   
In the present study, 4% dietary Noni supplement only increased the expression of 
TLR-3. This response may be due to the effects of phytochemicals on the TLR-3 signal 
transduction pathway, which uses interferon regulatory factor-3 (IRF-3) transcription 
factor to express antiviral products, in contrast to other TLRs that signal via the NF-kB 
transcription factor (Akira et al., 2004). This is supported by the fact that some 
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 phytochemicals like quercetin which is present in the Noni fruit, stimulate the production 
of interferon-γ (IFN-γ) an antiviral product (Park et al., 2009).  IFN-γ then acts in an 
autocrine manner and provides positive feedback for expression of TLR-3 via the JAK 
STAT pathway (Tanabe et al., 2003; Tohyama et al., 2005). However, at higher 
concentrations of phytochemicals, these might inhibit the expression of TLR-3 due to 
excessive production of IFN-γ which provides a negative feedback for TLR-3 gene 
expression (Dai et al., 2006). IFN-γ inhibition is due to production of SOCS (suppressors 
of cytokine signaling) which inhibits the signaling of IFN-γ via the JAK STAT pathway. 
The flavonoid, luteolin, also present in Noni fruit, suppresses the expression of interferon 
regulatory factor-3 at least at higher concentrations (50 µM). This might be another 
mechanism by which Noni suppresses gene expression of TLR-3 (Lee et al., 2009).  In 
the present study, the increased TLR-3 gene expression did not show any effect on 
measured cytokines and chemokine gene expression. This lack of response may be 
explained by the fact that neither TLR-4 nor TLR-5 were increased, and the increased 
then TLRs modulate the expression of cytokines (Schaefer et al., 2004) 
Noni at 6% increased 2.6 and 2.3 fold gene expression of Toll-like receptor-4 and 
-5, respectively but decreased the TLR-7 gene expression (Figure 4.4). These TLRs all 
share the common NF-kB pathways for gene expression. The increased expression of IL-
8 and IL-12 suggest that Noni polysaccharides bind to the TLR-4 at cell surface, since 
plant polysaccharides cannot enter cells. Also, Han et al. (2002, 2003) shown that 
polysaccharides bind with TLR-2 and -4 on the surface of immune cells and stimulate                               
production of various cytokines and chemokines by the NF-kB pathway. This is further 
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 supported by the findings that several polysaccharides isolated from plants have been 
shown to have immunostimulatory activities (Kim et al., 1996; Han et al., 1998). The 
activation of TLR-4 leads to its increased expression by both transcriptional and 
posttranslational mechanisms (Muzio et al., 2000; Yan et al., 2006). Stimulation of  TLR-
4 gene expression enhances expression of various proinflammatory cytokines and 
chemokine, including IL-12 and IL-8 in human mast cells and in broilers heterophils 
(Ferdous et al., 2008; Kirshenbaum et al., 2008). The results of this study agree with 
those findings. Our observed increased TLR-5 gene expression might be possibly due to 
the enhanced levels of cytokines. 
Reduced IL-6 gene expression might be one contributing factor for reduced TLR-
7 gene expression, since previous research has shown that IL-6 cytokine selectively 
increased the TLR-7 gene expression in humans (Zarember et al., 2002). Decreased IL-6 
expression might be associated with unaltered IL-1 gene expression, as IL-6 gene 
expression is mainly induced by IL-1 and TNF-α (Benveniste et al., 1990; Miyazawa et 
al., 1998). Interestingly, both IL-1 and TNF-α were decreased in a graded manner when 
dietary Noni treatment increased from 4 to 6%. Also, the location of TLR-7 on internal 
cellular endosomes might limit its stimulation by Noni polysaccharides, as they can not 
enter through the cell. In contrast, a number of phytochemicals that are present in Noni 
can easily enter the cell.  These might inhibit the basal expression level of TLR-7 and IL-
6. At the molecular level, the basal expression of TLR-7 and IL-6 is negatively regulated 
by SOCS, phosphatases, and some other inhibitory enzymes, any of which might be 
stimulated by Noni phytochemicals. Interestingly, in contrast to mammals, TLR-7 in 
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 chicken is not able to induce type I interferon in chicken and seems less important in viral 
infection (Philbin et al., 2005). 
In conclusion, the selectively increased TLR-3, TLR-4 and TLR-5 indicate that 
Noni fruit induces antiviral and antibacterial responses in chickens which is further 
strengthened by increased expression of IL-12 and IL-8 (Philbin et al., 2005). At the 
same time, decreased expression of TLR-7 and IL-6 indicated anti-inflammatory 
properties of Noni. Further investigations will be necessary to explore the active 
immunomodulatory ingredients of Noni and its effects during viral and bacterial 
infections.  
Noni at 4% and 6% could increase the concentration of serum IgG and IgM 
immunoglobulins. However, our lack of observing a significant effect might be due to the 
contribution of natural antibodies (NAb) on the total measured IgG or IgM. The NAb 
level against different or same antigens is affected by the linkage between the gene-
environment interactions, and different genetic origins of breeds, strains, and lines of 
chickens (Van der Zijpp et. al., 1983; Kundu et al., 1999; Parmentier et al., 2004, 
Hangalapura et al., 2003, Siwek et al., 2006).  However it is assumed that broilers are 
genetically similar due to selective line breeding but polygenic inheritance may be 
associated to natural antibody response against antigen in chicken (Siwek et al., 2006) 
and thus the interaction between more than two genes lead to the differences in natural 
antibody concentration among broilers.  
Further investigation is necessary to examine the effect of Noni using genetically 
uniform lines, or strains with reduced genetic variation with increased number of sample 
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 size in order to extend the observation of apparent antiviral/antibacterial properties by 
Noni after vaccination.  
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 Appendix A 
 
Extraction of IgA Antibody from Chicken Gut Tissue  
 
Materials required: 
1. Phosphate buffer saline tablet (Sigma-Aldrich, P4417) 0.01 M phosphate buffer, 
    pH 7.4. 
2. Trypsin inhibitor (Sigma-Aldrich, T-9003) @100 µg/ml in PBS. 
3. Glass beads of 1 mm diameter (Biospec Product Inc. 11079110). 
4. Centrifuge (Beckman- Coulter Microcentifuge 22R). 
 
Procedure: 
1. Dissolve one tablet of phosphate buffered saline in 200 ml of distilled water to 
obtain 0.01 M phosphate buffer saline. Trypsin inhibitor is added to PBS @ 100 
µg/ml.  
 
2. Weigh whole frozen intestinal tissue and its content as quick as possible to avoid 
thawing. 
 
3. Put Intestine tissue along with its content into 1.5 ml plastic vial. Add 1 ml of 
trypsin inhibited phosphate buffer saline into the vial and bring to final volume 
with glass beads. Tightly cap the vial and make sure there are no bubbles present. 
 
4. Homogenize the tissues in bead beater at 4800 rpm for 3 minutes. The 
homogenate gets warm after 3 minutes. To minimize heating during the extraction 
treatment prechill beads and buffer and stop for 60 seconds after each 60 seconds 
blending. Immediately place homogenates on ice. 
 
5. Decant homogenate or remove by pipetting after the beads settle to the bottom 
and transfer into the 1.5 ml high “g”micro centrifuge tubes.  
 
6. Centrifuge homogenate at 14000 X g for 10 minutes at 4 0C. 
 
7. Remove the supernatant from the pellet and discard the pellet. 
 
8. Store the supernatant at -80 0C until further analysis. 
 
 
Source: Haghighi, H. R., Gong, J., Gyles, C.L., Hayes, M.A., Sanei, B., Parvizi, P., Haris, G., 
J.R. Chamber and S. Sharif (2005). Modulation of antibody- mediated immune response by 
probiotics in chickens. Clinical and Diagnostic  Laboratory Immunology 12: 1387-1392    
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 Appendix B 
 
Collection of Tissue for RNA Extraction 
 
Introduction:  
RNases are present in cells and even the surrounding environment. They do not require a 
cofactor to cleave the RNA in a non-specific or specific manner. However, tissue RNA 
can be degraded by other non-specific mechanism, if samples are not stored properly. To 
prevent degradation of RNA, samples must be preserved either by storage at very low 
temperature (-800 C), in stabilizing reagents (RNAlater, Qiagen Inc.), or using a 
combination of both.  
 
Materials required  
1. Sterilized 5 ml RNA free collection vials  
2. Sterilized scissors  
3. Sterilized forceps    
4. Concentrated EtOH (95%)  
5. Test tube stand  
6. Permanent markers  
7. RNAlater RNA stabilization reagent  
8. Insulator box  with ice 
9. Gloves 
10. Sterilized syringe/droppers  
11. Sterilized normal saline solution  
12. Beaker 500 ml capacity (autoclaved and treated with 0.1% diethylpyrocarbonate 
water)  
13. Analytical balance  
 
Things to be considered before collection of tissue 
 RNAlater RNA stabilization reagent may form a precipitate during storage below 
room temperature (15-250 C). Before using the RNAlater RNA stabilization 
reagent, redissolve the precipitate by heating to 370 C with agitation. 
 Only fresh unfrozen tissue can be stabilized using RNAlater RNA stabilization 
reagent. 
 Amount of reagent needed per sample: Around 180-250 mg samples need 
approximately 2.5 ml of RNAlater RNA stabilization reagent. 
 Storage container should be wide enough so that the reagent covers the entire 
tissue.  
 The procedures for tissue harvesting and RNA stabilization should be carried out 
as quickly as possible. 
 Sample must be cut into slices less than 0.5 cm thick and immediately put in to 
the  stabilization reagent (If the slices are thicker than 0.5 cm the reagent will 
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 diffuse too slowly into the interior of the sample and RNA degradation will 
occur). 
 
 
Protocol for collection of tissue: 
1. Sterilize work area and instruments with 70% EtOH.  
2. Treat glass vials with 0.1% DEPC to eliminate RNAase. Pipette 10 x (estimated 
tissue mass) RNAlater RNA stabilization reagent into each vial and cap the vials. 
3. Collect tissue, take a suitable mass of sample, chop and place in vial with 
stabilization reagent. Make sure the level of stabilization reagent is well above the 
tissue. 
4. Place vials overnight at 2-80 C, then store at -200 C. 
       
 Precaution: 
1. Preparation of normal saline (0.89% W/V) in sterile water (water must be 
autoclaved and 0.1% diethylpyrocarbonate treated). 
2. Collection vials should be RNase free. Use glass vials and make them RNase free 
by 0.1% diethylpyrocarbonate treatment.    
3. If transporting tissue samples in RNAlater reagent, ensure that the tissue always 
remains submerged in the reagent. Either keep the tubes upright during transport 
or fill the tubes completely with RNAlater reagent. 
4. Stored tissue can be thawed at room temperature and frozen again for up to 20 
freeze-thaw cycles without affecting RNA quality or yield. 
 
    Source:  
    QIAGEN RNeasy® Mini Handbook, 4th edition (2006). 
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 Appendix C 
 
Extraction of Total RNA 
 
Introduction: 
 Biological samples are first lysed and homogenized in the presence of a highly 
denaturing guanidine-thiocyanate-containing buffer, which immediately inactivates 
RNases to ensure purification of intact RNA. Ethanol is added to provide appropriate 
binding conditions, and the sample is then applied to an RNeasy mini spin column. The 
total RNA binds to the membrane and contaminants are efficiently washed away. High- 
quality RNA is then eluted in 50 μl water. 
 
Materials required: 
Qiagen RNeasy® protect mini kit with required buffers (RLT, RPE, RW1 and RDD) 
2 ml RNase free polypropylene tubes  
Disposable blades 
Pestle and mortar 
Micropipettes / RNase free tips 
Liquid nitrogen  
Ethanol (96-100% and 70%) 
Centrifuge 
QIAshredder columns 
RNase-free DNase set 
Glass vials  
Thermocol box with ice (for maintain the temperature during the DNase preparation) 
 
Things to do before starting experiment: 
 Buffer RLT is prepared by adding 10 microliters of mercaptoethanol per 1 ml of 
RLT. It can be stored at room temperature for up to 1 month. 
 Before using for the first time, add 4 volumes of ethanol (96-100%) in 
concentrated buffer RPE as indicated to obtain a working solution. 
 70% ethanol is prepared using RNase free water. 
 DNase digest buffer is prepared by adding lyophilized DNase in buffer RDD. 
                                         
  Protocol:  
 
1. Remove RNAlater stabilized tissue from the reagent using forceps and remove 
any crystals that may have formed.  
 
2. Weigh the piece to be used (20 mg) directly into microcentrifuge tube. If 
necessary, cut tissue on a clean sterile surface with a sterile scalpel. 
 
3. Immediately place the weighed tissue in liquid nitrogen and grind thoroughly with 
a mortar and pestle. Decant tissue powder and liquid nitrogen into an RNase-free, 
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 liquid nitrogen-cooled, 2 ml microcentrifuge tube. Allow the liquid nitrogen to 
evaporate, but do not allow the tissue to thaw. 
 
4. Add 600 µl buffer RLT, vortex it and pipette the lysate directly into a 
QIAshredder spin column placed in a 2 ml collection tube, and centrifuge for 2 
minutes at full speed at room temperature. 
 
5. Discard the QIA shredder column. 
 
6. Centrifuge the lysate for 3 minutes at full speed. Carefully remove the supernatant 
by pipetting and transfer it to a new microcentrifuge tube. Use only this 
supernatant (lysate) in subsequent steps.  
 
7. Add 1 volume of 70% ethanol to the cleared lysate and mix immediately by 
pipetting. Do not centrifuge. Immediately proceed to step 8 (precipitate may be 
visible after addition of ethanol. This does not affect the procedure) 
 
8. Transfer up to 700 μl of the sample, including any precipitate that may have 
formed, to an RNeasy spin column placed in a 2 ml collection tube (supplied by 
Qiagen). Centrifuge for 15 s at 10,000 rpm. Discard the flow through. If the 
sample volume exceeds 700 μl, centrifuge successive aliquots in the same RNeasy 
spin column. Discard the flow-through after each centrifugation. 
 
9. Add 350 μl of buffer RW1 to the RNeasy spin column and centrifuge for 15 s at 
10,000 rpm to wash the spin column membrane. Discard the flow through. Retain 
the collection tube for reuse in step 11. 
 
10. Add 80 μl DNase I directly to the RNeasy spin column membrane, and place on 
the bench top (for 15 minutes). Be sure to add the DNase I incubation mix directly 
to the RNeasy spin column membrane. DNase digestion will be incomplete if part 
of the mix sticks to the wall or the O-ring of the spin column. 
 
11. Add 350 μl Buffer RW1 to the RNeasy spin column and centrifuge for 15 s at 
more than or equal to 10,000 rpm. Discard the flow-through. Transfer RNeasy 
column to a new 2 ml collection tube. 
 
12.  Add 500 µl of buffer RPE to the RNeasy spin column and centrifuge for 15 s at 
10,000 rpm to wash the spin column membrane. Discard the flow through. 
 
13. Add another 500 μl of buffer RPE to the RNeasy spin column and centrifuge for 2 
minutes at 10,000 rpm to wash the spin column membrane.  
 
14. Place column in a new 2 ml collection tube and discard the flow through after 
centrifugation for 1 minute. 
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15. Transfer column to a new 1.5 ml collection tube (supplied in kit). Add 50 μl of 
RNase free water directly onto the column and keep it for 1 minute at room 
temperature. Close tube and centrifuge at 10,000 rpm for 1 minute to elute.  
              
Source:  
QIAGEN RNeasy® Mini Handbook, 4th edition (2006). 
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 Appendix D 
 
Conversion of mRNA to cDNA and Amplification of cDNA 
 
Introduction: 
Use of the QuantiTect SYBR Green RT-PCR master mix containing reverse transcriptase 
together with the QuantiTect RT Mix containing DNA polymerase allow both reverse 
transcription and amplification of transcript in a single tube.  
 
Material required:                            
QuantiTect SYBR Green RT-PCR Kit 
Primers  
96 well plates for the reactions 
Plate covers 
Ice box with ice 
RNase free water  
Pipettes: 2 µl, 20 μl, 200 µl and 1000 μl 
RNase free tips for measurements 
Real time cycler 
Extracted RNA 
RNase free water  
Gloves 
Sterile 1.5 ml of centrifuge tubes  
 
Things to do before starting: 
  
 Adjust the RNA concentration in RNase free water in such a manner that all RNA 
concentration must be equal to 10 ng per 10 µl of volume. 
 Calculate the amount of master mix needed for the reactions according to Table 1. 
Multiply the individual volumes with number of samples.    
 Make the PCR plate template and set temperature and time program in the 
computer software attached with thermocycler day before planning to run 
samples. Check the direction of putting PCR plate in the Real time cycler.  
 Thawing should be performed at ice temperature. 
 Dilute the final concentration of primer to 0.5 μM in RNase free water. 
                                                        
Protocol:  
1. Thaw 2x QuantiTect SYBR Green RT-PCR Master Mix (if stored at -200 C), template 
RNA, primers, and RNase- free water at ice. Mix the individual solutions, and place them 
on ice. The QuantiTect RT Mix should be taken from -200 C immediately before use, 
always kept on ice, and returned to storage at -200 C immediately after use. 
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 Table 1: Different volumes of 25 μl reaction mixture. 
 
Component Volume/reaction Concentration 
2x QuantiTect SYBR Green 
RT-PCR Master Mix 
12.5 μl   
Primer forward 0.5 μl 0.5 μM 
Primer backward 0.5 μl 0.5 μM 
QuantiTect RT Mix  0.25 μl 0.25 μl / reaction 
RNase- free water 1.25  
Template RNA ( added at 
step 5) 
10 μl 1ng/ μl  
 Total volume  25 μl  
 
2. Vortex the Primers and master mix, and mix the RT solution by gentle tapping. Do not      
     centrifuge any of them.    
                                         
3. Each mixed component is then dispensed in 96 well PCR plate as following order and  
final volume adjusted to 25 µl with RNase free water:    
   A. RNase free water         B. master mix          C. RT (reverse transcriptase) 
 
4. Add template RNA to the individual PCR wells containing reaction mixture . This may 
be done prior to step 3.  
 
5. Seal the plate with sealer 
 
6. Program the Real time cycler according to the program outlined : 
One cycle of  
 50 0C for 30 minutes (Reverse transcription) 
 950 C for 15 minutes (DNA polymerase is activated, reverse transcriptases are 
deactivated and template cDNA is denatured) 
 
 Followed by 40 cycles of 
 940 C for 15 seconds (Denaturation) 
 570 C for 20 seconds (anneling)  
 720 C for 20 seconds (extension)  
 
7. Data acquisition should be performed during the extension step. 
 
8. Keep samples on ice until the Real time cycler is programmed. Place the PCR tubes or  
    plates in the thermal cycler and start the cycling program. 
 
Source: 
Qiagen kit manual for quantitative, real time, one step RT-PCR, November, 2000 
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 Appendix E 
 
Conversion of mRNA to cDNA and Amplification of cDNA for Gel Electrophoresis 
 
Introduction:  
Reverse transcriptase is used to convert the mRNA to cDNA using oligo dT primers. The 
resulting cDNA are amplified using specific primers for the specific gene expression in 
separate tube.   
 
Material required:                            
Protoscript ® II RT-PCR Kit  
Primers  
Polyacrylamide gel 1.5%  
Camera  
Illuminometer 
PCR tubes 
100 bp Ladder Aluminium foil 
Ice box  
RNase free water (DEPC treated water) 
Dye (Ethidium bromide) 
6X loading dye 
Thermocycler  
 
First Strand cDNA Synthesis: 
Proper precautions should be used to avoid ribonuclease contamination. This includes the 
use of autoclaved tubes, baked glassware, ultra-pure solutions, sterile pipette tips and 
latex gloves during manipulations  
 
1. Thaw system components and place on ice. The 10X RT Buffer can be warmed briefly   
     at 42°C and vortexed to dissolve any precipitate. (Note: It is important to set up a -RT  
     control reaction (no reverse transcriptase) to insure there is no DNA contamination). 
 
2. Make the RNA/primer/dNTP mix by combining the following components in a PCR   
    tube:  
                                         Total RNA                :  1–10 μl (2 μg)  
                                         Primer dT23VN        :  2 μl  
                                         dNTP Mix                 :  4 μl  
                                         Nuclease-free water  :  variable  
                                        Total volume              : 16 μl 
 
3. Heat for 5 minutes at 70°C. Spin briefly and promptly chill on ice. 
 
 
4. Add the following components to the 16 μl RNA/primer/dNTP solution and mix well   
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     by pipetting up and down:  
                                                                                                   - RT control  
     10X RT Buffer                   2 μl                                                   2 μl  
     RNase Inhibitor               0.5 µl                                                0.5 µl  
     Reverse Transcriptase        1 µl                                                     – 
     Nuclease-free water        0.5 µl                                                 1.5 µl  
     Final volume                    20 μl                                                 20 µl 
 
4. Incubate the 20 μl cDNA synthesis reaction mixture at 42°C for one hour.  
 
5. Inactivate the enzyme at 80°C for 5 minutes. 
 
6. Bring the reaction volume to 50 μl with water. The cDNA product should be stored at   
    –20°C. 
                                              
PCR Amplification: 
1. Mix the following in a PCR tube on ice:  
Taq 2X Master Mix                         25 μl (mix well by inverting before use)  
Forward Primer (10 μM)                   1 μl (final concentration 200 nm)  
Reverse Primer (10 μM)                    1 μl (final concentration 200 nm)  
Diluted cDNA                                 2.5 or variables 
H20 variable                                   20.5 or variables 
Total volume                                    50 µl 
 
2. Mix gently and allowed the reaction to proceed under the following condition:  
 
  Initial denaturation 95°C 1 minute 
  35-40 Cycles 94°C 
57°C 
68°C 
30 seconds 
30 seconds 
1 minute per kb 
  Final Extension 68°C 10 minutes 
 
3. Optimize cycle numbers to prevent the amount of PCR product from exceeding the   
    upward slope of a typical cycle number-PCR product. Apply 35 cycles for IL-8 and    
    TLR-7 assays and 40 cycles for IL-12 assay. 
 
Quantification: 
1. Separate gene specific PCR products in 1.5% agarose gels using 0.02% ethidium   
    bromide for visualization. 
 
2. Quantify band intensity in ultraviolet light using illuminometer and Image J software    
    (www.rsb.info.nih.gov). Target gene is expressed relative to the internal control   
    (GAPDH). 
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Source: 
 Protoscript® M-MuLV Taq RT-PCR kit instructional manual, New England Biolabs Inc., 
MA 
 
 
 
 
  
 
Appendix F 
 
Primer Sequences 
Genes Direction                 *Primer sequences (5’-3’)  Accession no.   Product size (bp) 
Forward GCTCTACATGTCGTGTGTGATGAG IL-1β  Backward TGTCGATGTCCCGCATGA 
Y15006 75 
Forward ATGTGCAAGAAGTTCACCGTGTGC IL-6  Backward TTCCAGGTAGGTCTGAAAGGCGAA 
AJ309540 171 
Forward TTTCAGCTGCTCTGTCGCAAGGTA IL-8  
 Backward CTTGGCGTCAGCTTCACATCTTGA   
DQ393272 
 127 
Forward TGTCTCACCTGCTATTTGCCTTAC  IL-12 Backward CATACACATTCTCTCTAAGTTTCCACTGT 
NM_213571 87 
Forward ACCCGGATTGCAGTCTCAGTACAT TLR-3 Backward TGTCCTTGCAGGCTGAGGTATCAA 
NM_001011691
 92 
Forward GTTGCTTGCTGCAGGAGTGTTTCT TLR-4 Backward AGGGTTCCACCAGCTCTTTCATCA 
AY064697 179 
Forward TGAACTCCAGCAGACACTCAGGTT TLR-5 Backward TGCAGGTGGATGGCTTCCTATCAA 
NM_001024586 160 
Forward ATCTGACGGTGTTGGATCTTGGGA TLR-7 Backward ACGTGCCTGCTGTATTGCTCTACT 
FJ915600 
 187 
Forward ATGCCATCACAGCCACACAGAAGA GAPDH Backward GCACACGGAAAGCCATTCCAGTAA 
NM_204305 171 
 
 
 
          * Primers were designed using PrimerQuest software (www.idtdna.com, integrated DNA Technology, Iowa) 
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